Related references
Note: Only part of the references are listed.Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
Jan C. Holter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N. Ramasamy et al.
LANCET (2020)
Regulatory T Cells Control PF4/Heparin Antibody Production in Mice
Yongwei Zheng et al.
JOURNAL OF IMMUNOLOGY (2019)
Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia
Mehraboon Irani et al.
TRANSFUSION (2019)
Autoimmune heparin-induced thrombocytopenia
A. Greinacher et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Heparin-induced multi-electrode aggregometry method for heparin-induced thrombocytopenia testing: communication from the SSC of the ISTH
M. -C. Morel-Kopp et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia
Yongwei Zheng et al.
BLOOD (2014)
Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: Confirmation in a prospective study
Vassiliki Galea et al.
PLATELETS (2013)
Platelet Factor 4/Heparin Antibodies in Blood Bank Donors
Marcie J. Hursting et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
The use of well-characterized sera for the assessment of new diagnostic enzyme-immunoassays for the diagnosis of heparin-induced thrombocytopenia
T. E. Warkentin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Share Paper
